Clinical Validation and Study Design

Moving beyond technical performance to demonstrate that an AI model provides real clinical value. This section bridges the gap between model development and clinical evidence.


5.1

Technical Validation vs. Clinical Validation: Understanding the Differencesoon

Why strong performance on a test set is necessary but not sufficient. The hierarchy of evidence for AI: standalone performance, reader studies, comparative studies, and outcome studies.

5.2

Designing Retrospective Validation Studiessoon

How to design rigorous retrospective studies using existing clinical data. Cohort selection, temporal validation, handling missing data, and the limitations of retrospective evidence.

5.3

Designing Prospective Clinical Validation Studiessoon

Study design for prospective AI validation: endpoints, control arms, randomization, blinding, enrichment strategies, and when a prospective study is necessary versus optional.

5.4

Multi-Site External Validationsoon

Why external validation across multiple sites and populations is the gold standard for demonstrating generalizability, and practical approaches to building multi-site collaborations.

5.5

Reader Studies: Measuring AI's Impact on Clinical Decision-Makingsoon

Designing and interpreting reader studies (with-AI vs. without-AI paradigms). Crossover designs, washout periods, reader selection, and measuring the effect on diagnostic accuracy and efficiency.

5.6

Defining Clinically Meaningful Endpointssoon

Moving beyond surrogate metrics to endpoints that matter: diagnostic accuracy against a meaningful reference standard, time to diagnosis, treatment outcomes, and patient-centered measures.

5.7

Reference Standards and Ground Truth in Medical AIsoon

The challenge of defining "truth" when expert clinicians disagree. Consensus panels, adjudication protocols, imperfect reference standards, and their impact on reported model performance.